Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands		Total	Convertible Preferred Stock	Preferred Stock Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (loss) Income
Balance, before retroactive conversion		$ (55,692)		$ 87,140	$ 2	$ 6,521	$ (62,215)	$ 0
Retroactive application					$ (1)	1
Retroactive application, shares	[1]			(152,677,720)	(17,972,432)
Balance, before retroactive conversion, shares	[1]			199,145,285	23,442,353
Beginning balance at Dec. 31, 2022		(55,692)		$ 87,140	$ 1	6,522	(62,215)	0
Beginning balance, shares at Dec. 31, 2022	[1]			46,467,565	5,469,921
Issuance of common stock upon exercise of stock options		92				92
Issuance of common stock upon exercise of stock options, shares	[1]				140,545
Stock-based compensation expense		366				366
Issuance of common stock in connection with the acquisition of fSight, shares	[1]				1,306,385
Issuance of common stock in connection with the acquisition of fSight		10,077				10,077
Unrealized gain (loss) resulting from change in fair value of marketable securities		14						14
Net income (loss)		6,910					6,910
Ending balance, shares at Mar. 31, 2023	[1]			46,467,565	6,916,851
Ending balance at Mar. 31, 2023		(38,233)		$ 87,140	$ 1	17,057	(55,305)	14
Beginning balance at Dec. 31, 2022		(55,692)		$ 87,140	$ 1	6,522	(62,215)	0
Beginning balance, shares at Dec. 31, 2022	[1]			46,467,565	5,469,921
Net income (loss)		(15,266)
Ending balance, shares at Jun. 30, 2023	[1]			0	58,144,543
Ending balance at Jun. 30, 2023		30,434		$ 0	$ 6	120,671	(90,062)	(181)
Beginning balance at Mar. 31, 2023		(38,233)		$ 87,140	$ 1	17,057	(55,305)	14
Beginning balance, shares at Mar. 31, 2023	[1]			46,467,565	6,916,851
Issuance of common stock upon exercise of stock options		14				14
Issuance of common stock upon exercise of stock options, shares	[1]				10,784
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes		(91)				(91)
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes, shares	[1]				(11,832)
Stock-based compensation expense		497				497
Unrealized gain (loss) resulting from change in fair value of marketable securities		(195)						(195)
Convertible preferred stock dividends, shares	[1]			1,258,055
Convertible preferred stock dividends						12,581	(12,581)
Issuance of preferred stock upon exercise of preferred warrants		2,008				2,008
Issuance of preferred stock upon exercise of preferred warrants, shares	[1]		193,372
Conversion of convertible preferred stock into common stock in connection with the Business Combination		87,140	$ (87,140)		$ 5	87,135
Conversion of convertible preferred stock into common stock in connection with the Business Combination, shares	[1]		(47,918,992)		47,918,992
Issuance of common stock upon exercise of common warrants, shares	[1]				1,491,229
Purchase price adjustment in connection with the fSight acquisition		897				897
Issuance of common stock upon Business Combination, shares					1,818,519
Issuance of common stock upon Business Combination, value		573				573
Net income (loss)		(22,176)					(22,176)
Ending balance, shares at Jun. 30, 2023	[1]			0	58,144,543
Ending balance at Jun. 30, 2023		30,434		$ 0	$ 6	120,671	(90,062)	(181)
Beginning balance at Dec. 31, 2023		62,824			$ 6	138,657	(75,780)	(59)
Beginning balance, shares at Dec. 31, 2023					58,751,666
Issuance of common stock upon exercise of stock options		250				250
Issuance of common stock upon exercise of stock options, shares					755,016
Stock-based compensation expense		2,505				2,505
Issuance of common stock in connection with the acquisition of fSight, shares					166,271
Issuance of common stock in connection with the acquisition of fSight		239				239
Issuance of common stock in connection with employee incentive stock awards, shares					685,213
Unrealized gain (loss) resulting from change in fair value of marketable securities		12						12
Net income (loss)		(11,506)					(11,506)
Ending balance, shares at Mar. 31, 2024					60,358,166
Ending balance at Mar. 31, 2024		54,324			$ 6	141,651	(87,286)	(47)
Beginning balance at Dec. 31, 2023		$ 62,824			$ 6	138,657	(75,780)	(59)
Beginning balance, shares at Dec. 31, 2023					58,751,666
Issuance of common stock upon exercise of stock options, shares		768,837
Net income (loss)		$ (22,827)
Ending balance, shares at Jun. 30, 2024					60,371,987
Ending balance at Jun. 30, 2024		44,740			$ 6	143,364	(98,607)	(23)
Beginning balance at Mar. 31, 2024		54,324			$ 6	141,651	(87,286)	(47)
Beginning balance, shares at Mar. 31, 2024					60,358,166
Issuance of common stock upon exercise of stock options		10				10
Issuance of common stock upon exercise of stock options, shares					13,821
Stock-based compensation expense		1,703				1,703
Unrealized gain (loss) resulting from change in fair value of marketable securities		24						24
Net income (loss)		(11,321)					(11,321)
Ending balance, shares at Jun. 30, 2024					60,371,987
Ending balance at Jun. 30, 2024		$ 44,740			$ 6	$ 143,364	$ (98,607)	$ (23)

[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.233335 established in the Business Combination as described in Note 3.